Paper Details

  1. Home
  2. Paper Details

Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up.

Author:

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

The LIPID study showed that pravastatin therapy over 6 years reduced mortality and cardiovascular events in patients with previous acute coronary syndromes. Long-term follow-up over 8 years further confirmed the beneficial effects of pravastatin on cardiovascular events and mortality.
Paper Details　
Original Abstract of the Article :
The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) study showed that pravastatin therapy over 6 years reduced mortality and cardiovascular events in patients with previous acute coronary syndromes and average cholesterol concentrations. We assessed the longer-term effects of in...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/S0140-6736(02)08351-4

データ提供：米国国立医学図書館（NLM）

Long-Term Benefits of Pravastatin in Coronary Heart Disease

Cardiovascular disease remains a significant public health concern, with researchers continually seeking ways to improve prevention and treatment. This research examines the long-term effects of pravastatin therapy in patients with coronary heart disease. The study, a follow-up to the LIPID trial, aimed to assess the impact of pravastatin on mortality and cardiovascular events over an extended period. The findings provide crucial insights into the long-term benefits of this medication for individuals with coronary heart disease.

Pravastatin: A Long-Term Ally in Heart Health

The study found that initial treatment with pravastatin significantly reduced mortality and cardiovascular events in patients with coronary heart disease, even over an extended period of eight years. This suggests that pravastatin can have a lasting positive impact on cardiovascular health, offering hope for individuals living with this chronic condition. The study’s findings highlight the importance of long-term medication adherence in achieving optimal health outcomes.

Heart Health: A Lifelong Journey

This research emphasizes the importance of ongoing cardiovascular care. It is like a journey through a vast desert; you need a reliable guide and the right tools to navigate the challenges. Pravastatin can be seen as a valuable tool, offering long-term protection for individuals with coronary heart disease. Understanding the benefits of medication and adhering to a doctor’s recommendations are crucial steps in managing cardiovascular health and ensuring a fulfilling life.

Dr.Camel's Conclusion

This study offers a glimmer of hope in the desert of cardiovascular disease. It highlights the potential of pravastatin to provide long-term cardiovascular protection for individuals with coronary heart disease. It reminds us of the importance of adhering to long-term treatment plans and embracing a holistic approach to heart health. Let’s continue our journey of discovery and innovation in this vital field.

Date :
  1. Date Completed 2002-05-08
  2. Date Revised 2015-06-16
Further Info :

Pubmed ID

11978335

DOI: Digital Object Identifier

10.1016/S0140-6736(02)08351-4

Related Literature

Article Analysis
・Effects of pravastatin
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.